BE-13-XC52_1uM Gene Set
Genes
17 genes differentially expressed following the BE-13-XC52_1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.
increased expression
| Symbol |
Name |
Standardized Value |
|
UBA52
|
ubiquitin A-52 residue ribosomal protein fusion product 1
|
1.02544
|
|
APRT
|
adenine phosphoribosyltransferase
|
0.765015
|
|
ELOB
|
elongin B
|
0.491587
|
|
RPS27
|
ribosomal protein S27
|
0.45676
|
|
UBC
|
ubiquitin C
|
0.424712
|
|
RPL36
|
ribosomal protein L36
|
0.424712
|
|
RPL8
|
ribosomal protein L8
|
0.326089
|
|
RPS15
|
ribosomal protein S15
|
0.316531
|
|
RPL37A
|
ribosomal protein L37a
|
0.295894
|
|
RPLP2
|
ribosomal protein, large, P2
|
0.288614
|
|
CRYAB
|
crystallin, alpha B
|
0.218253
|
|
FAU
|
Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed
|
0.212338
|
|
RPS18
|
ribosomal protein S18
|
0.210603
|
|
C19ORF33
|
chromosome 19 open reading frame 33
|
0.208098
|
|
LDHB
|
lactate dehydrogenase B
|
0.201496
|
decreased expression
| Symbol |
Name |
Standardized Value |
|
SMARCD1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1
|
-0.495013
|
|
CAMKK2
|
calcium/calmodulin-dependent protein kinase kinase 2, beta
|
-0.268642
|